{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T16:44:21Z","timestamp":1776876261790,"version":"3.51.2"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Science Inc"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1007\/s11906-006-0029-4","type":"journal-article","created":{"date-parts":[[2007,5,24]],"date-time":"2007-05-24T15:53:05Z","timestamp":1180021985000},"page":"497-501","source":"Crossref","is-referenced-by-count":11,"title":["Management of hypertension in chronic kidney disease"],"prefix":"10.1007","volume":"8","author":[{"given":"Pasquale","family":"Zamboli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"De Nicola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Minutolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerio","family":"Bertino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fausta","family":"Catapano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Conte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"29_CR1","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/sj.ki.5000085","volume":"69","author":"L Nicola De","year":"2006","unstructured":"De Nicola L, Minutolo R, Chiodini P, et al.: Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. Kidney Int 2006, 69:538\u2013545. This is the largest recent systematic survey on the implementation of therapeutic goals in a population of CKD patients regularly followed by nephrologists in the real world of clinical practice.","journal-title":"Kidney Int"},{"key":"29_CR2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0272-6386(96)90380-7","volume":"28","author":"VM Buckalew Jr","year":"1996","unstructured":"Buckalew VM Jr, Berg RL, Wang SR, et al.: Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. Am J Kidney Dis 1996, 28:811\u2013821.","journal-title":"Am J Kidney Dis"},{"key":"29_CR3","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/archinte.163.13.1555","volume":"163","author":"GL Bakris","year":"2003","unstructured":"Bakris GL, Weir MR, Shanifar S, et al.: Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study. Arch Int Med 2003, 163:1555\u20131565.","journal-title":"Arch Int Med"},{"key":"29_CR4","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7326\/0003-4819-139-4-200308190-00006","volume":"139","author":"TH Jafar","year":"2003","unstructured":"Jafar TH, Stark PC, Schmid CH, et al.: Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Inter Med 2003, 139:244\u2013252.","journal-title":"Ann Inter Med"},{"key":"29_CR5","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1053\/ajkd.2000.16225","volume":"36","author":"GL Bakris","year":"2000","unstructured":"Bakris GL, Williams M, Dworkin L, et al.: Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 2000, 36:646\u2013661.","journal-title":"Am J Kidney Dis"},{"key":"29_CR6","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1053\/j.ajkd.2004.01.009","volume":"43","author":"L Nicola De","year":"2004","unstructured":"De Nicola L, Minutolo R, Bellizzi V, et al.: Achievement of target blood pressure levels in chronic kidney disease: a salty question? Am J Kidney Dis 2004, 43:782\u2013795.","journal-title":"Am J Kidney Dis"},{"key":"29_CR7","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","volume":"108","author":"MJ Sarnak","year":"2003","unstructured":"Sarnak MJ, Levey AS, Schoolwerth AC, et al.: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003, 108:2154\u20132169. This review identifies and extensively comments for the first time the relevance of CKD as major independent cardiovascular risk factor.","journal-title":"Circulation"},{"key":"29_CR8","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/archinte.164.6.659","volume":"164","author":"DS Keith","year":"2004","unstructured":"Keith DS, Nichols GA, Gullion CM, et al.: Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Inter Med 2004, 164:659\u2013663.","journal-title":"Arch Inter Med"},{"key":"29_CR9","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, et al.: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004, 351:1296\u20131305.","journal-title":"N Engl J Med"},{"key":"29_CR10","doi-asserted-by":"crossref","first-page":"342","DOI":"10.7326\/0003-4819-142-5-200503010-00009","volume":"142","author":"MJ Sarnak","year":"2005","unstructured":"Sarnak MJ, Greene T, Wang X, et al.: The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann Int Med 2005, 142:342\u2013351.","journal-title":"Ann Int Med"},{"key":"29_CR11","doi-asserted-by":"crossref","unstructured":"K\/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004, 43(5 Suppl 1):S1\u2013S290.","DOI":"10.1053\/j.ajkd.2004.03.003"},{"key":"29_CR12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/01.hjh.0000202819.48577.a1","volume":"24","author":"R Marin","year":"2006","unstructured":"Marin R, Fernandez-Vega F, Gorostidi M, et al.: Blood pressure control in patients with chronic renal insufficiency in Spain: a cross-sectional study. J Hypertens 2006, 24:395\u2013402.","journal-title":"J Hypertens"},{"key":"29_CR13","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1681\/ASN.2005070756","volume":"17","author":"V Bellizzi","year":"2006","unstructured":"Bellizzi V, Scal. L, Terracciano V, et al.: Early changes in bioelectrical estimates of body composition in chronic kidney disease. J Am Soc Nephrol 2006, 17:1481\u20131487.","journal-title":"J Am Soc Nephrol"},{"key":"29_CR14","first-page":"1297","volume":"10","author":"Dorhout","year":"1995","unstructured":"Dorhout, Mees EJ: Volaemia and blood pressure in renal failure: Have old truths been forgotten? Nephrol Dial Transplant 1995, 10:1297\u20131298.","journal-title":"Nephrol Dial Transplant"},{"key":"29_CR15","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1046\/j.1523-1755.2003.00273.x","volume":"64","author":"N Vasawada","year":"2003","unstructured":"Vasawada N, Agarwal R: Role of excess volume in the pathophysiology of hypertension in chronic kidney disease. Kidney Int 2003, 64:1772\u20131779.","journal-title":"Kidney Int"},{"key":"29_CR16","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.jhh.1001459","volume":"16","author":"FJ He","year":"2002","unstructured":"He FJ, MacGregor GA: Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens 2002, 16:761\u2013770.","journal-title":"J Hum Hypertens"},{"key":"29_CR17","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1681\/ASN.V72306","volume":"7","author":"B Cianciaruso","year":"1996","unstructured":"Cianciaruso B, Bellizzi V, Minutolo R, et al.: Renal adaptation to dietary sodium restriction in moderate renal failure resulting from chronic glomerular disease. J Am Soc Neprol 1996, 7:306\u2013313.","journal-title":"J Am Soc Neprol"},{"key":"29_CR18","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1161\/01.HYP.7.5.714","volume":"7","author":"HA Koomans","year":"1985","unstructured":"Koomans HA, Roos JC, Dorhout Mees EJ, Delawi IM: Sodium balance in renal failure: A comparison of patients with normal subjects under extremes of sodium intake. Hypertension 1985, 7:714\u2013721.","journal-title":"Hypertension"},{"key":"29_CR19","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1046\/j.1523-1755.2003.00282.x","volume":"64","author":"BR Iorio Di","year":"2003","unstructured":"Di Iorio BR, Minutolo R, De Nicola L, et al.: Supplemented very low protein diet ameliorates responsiveness to erythropoietin in chronic renal failure. Kidney Int 2003, 64:1822\u20131828.","journal-title":"Kidney Int"},{"key":"29_CR20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11906-005-0076-2","volume":"7","author":"SI Mishra","year":"2005","unstructured":"Mishra SI, Jones-Burton C, Fink JC, et al.: Does dietary salt increase the risk for progression of kidney disease? Current Hypertens Rep 2005, 7:385\u2013391.","journal-title":"Current Hypertens Rep"},{"key":"29_CR21","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000057385","volume":"24","author":"B Cianciaruso","year":"1998","unstructured":"Cianciaruso B, Bellizzi V, Minutolo R, et al.: Salt intake and renal outcome in patients with progressive renal disease. Miner Electrolyte Metab 1998, 24:296\u2013301.","journal-title":"Miner Electrolyte Metab"},{"key":"29_CR22","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/ki.1987.71","volume":"31","author":"G Navis","year":"1987","unstructured":"Navis G, de Jong PE, Donker AJ, et al.: Moderate sodium restriction in hypertensive subjects: renal effects of ACE-inhibition. Kidney Int 1987, 31:815\u2013819.","journal-title":"Kidney Int"},{"key":"29_CR23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.7326\/0003-4819-125-3-199608010-00007","volume":"125","author":"GL Bakris","year":"1996","unstructured":"Bakris GL, Smith A: Effects of sodium intake on albumin excretion in patients with diabetic nephropathy treated with long-acting calcium antagonists. Arch Intern Med 1996, 125:201\u2013204.","journal-title":"Arch Intern Med"},{"key":"29_CR24","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2337\/diacare.25.4.663","volume":"25","author":"C Houlihan","year":"2002","unstructured":"Houlihan C, Allen TJ, Baxter AL, et al.: Low-sodium diet potentiates the effects of losartan in Type 2 diabetes. Diabetes Care 2002, 25:663\u2013671.","journal-title":"Diabetes Care"},{"key":"29_CR25","first-page":"S173","volume":"27","author":"B Cianciaruso","year":"1989","unstructured":"Cianciaruso B, Capuano A, D\u2019Amaro E, et al.: Dietary compliance to a low protein and phosphate diet in patients with chronic renal failure. Kidney Int Suppl 1989, 27:S173-S176.","journal-title":"Kidney Int Suppl"},{"key":"29_CR26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000089439","volume":"24","author":"E Ritz","year":"2006","unstructured":"Ritz E, Dikow R, Morath C, Schwenger V: Salt--a potential \u2018uremic toxin\u2019? Blood Purif 2006, 24:63\u201366.","journal-title":"Blood Purif"},{"key":"29_CR27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJM199808063390607","volume":"339","author":"DC Brater","year":"1998","unstructured":"Brater DC: Diuretic therapy. N Engl J Med 1998, 339:387\u2013395.","journal-title":"N Engl J Med"},{"key":"29_CR28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1042\/cs0680255","volume":"68","author":"Canton A Dal","year":"1985","unstructured":"Dal Canton A, Fuiano G, Conte G, et al.: Mechanism of increased plasma urea after diuretic therapy in uraemic patients. Clin Sci 1985, 68:255\u2013261.","journal-title":"Clin Sci"},{"key":"29_CR29","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1046\/j.1523-1755.2003.00124.x","volume":"64","author":"N Vasavada","year":"2003","unstructured":"Vasavada N, Saha C, Agarwal R: A double-blind randomized crossover trail of two loop diuretics in chronic kidney disease. Kidney Int 2003, 64:632\u2013640.","journal-title":"Kidney Int"},{"key":"29_CR30","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1172\/JCI114470","volume":"85","author":"A Remuzzi","year":"1990","unstructured":"Remuzzi A, Puntorieri S, Battaglia C, et al.: Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest 1990, 85:541\u2013549.","journal-title":"J Clin Invest"},{"key":"29_CR31","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/01.RES.61.4.531","volume":"61","author":"T Yoshioka","year":"1987","unstructured":"Yoshioka T, Rennke HG, Salant DJ, et al.: Role of abnormally high transmural pressure in the permselectivity defect of glomerular capillary wall: a study in early passive Heymann nephritis. Circ Res 1987, 61:531\u2013538.","journal-title":"Circ Res"},{"key":"29_CR32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2215\/CJN.00840805","volume":"1","author":"N Klosa","year":"2006","unstructured":"Klosa N, Bakris G: Lessons learned from recent hypertension trials about kidney disease. Clin J Am Soc Nephrol 2006, 1:229\u2013235.","journal-title":"Clin J Am Soc Nephrol"},{"key":"29_CR33","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","volume":"329","author":"EJ Lewis","year":"1993","unstructured":"Lewis EJ, Hunsicker LG, Bain RP, Rhode RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993, 329:1456\u20131462.","journal-title":"N Engl J Med"},{"key":"29_CR34","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1056\/NEJMoa042274","volume":"351","author":"AH Barnett","year":"2004","unstructured":"Barnett AH, Bain SC, Bouter P, et al.: Angiotensin-receptor blockade versus converting enzyme inhibition in type 2 diabetes and nephropathy. N Engl J Med 2004, 351:1952\u20131961.","journal-title":"N Engl J Med"},{"key":"29_CR35","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","volume":"345","author":"BM Brenner","year":"2001","unstructured":"Brenner BM, Cooper ME, De Zeeuw D, et al.: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001, 345:861\u2013869.","journal-title":"N Engl J Med"},{"key":"29_CR36","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","volume":"345","author":"EJ Lewis","year":"2001","unstructured":"Lewis EJ, Hunsicker LG, Clarke WR, et al.: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001, 345:851\u2013860.","journal-title":"N Engl J Med"},{"key":"29_CR37","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/ndt\/gfl013","volume":"21","author":"T Miyata","year":"2006","unstructured":"Miyata T, van Ypersele de Strihou: Renoprotection of angiotensin receptor blockers: beyond blood pressure lowering. Nephrol Dial Transplant 2006, 21:846\u2013849.","journal-title":"Nephrol Dial Transplant"},{"key":"29_CR38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(03)12229-5","volume":"361","author":"N Nakao","year":"2003","unstructured":"Nakao N, Yoshimura A, Morita H, et al.: Combination treatment of angiotensin-II receptor blocker and angiotensinconverting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomized controlled trial. Lancet 2003, 361:117\u2013124. This is the largest study of efficacy of combination therapy with CEI+ARB on prevention of CKD progression.","journal-title":"Lancet"},{"key":"29_CR39","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/sj.ki.5001732","volume":"70","author":"R Minutolo","year":"2006","unstructured":"Minutolo R, Balletta M, Catapano F, et al.: Mesangial hypercellularity predicts antiproteinuric response to dual blocked of RAS in primary glomerulonephritis. Kidney Int 2006, 70:1170\u20131176.","journal-title":"Kidney Int"},{"key":"29_CR40","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1056\/NEJMoa053107","volume":"354","author":"FF Hou","year":"2006","unstructured":"Hou FF, Zhang X, Zhang GH, et al.: Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med 2006, 354:131\u2013140.","journal-title":"N Engl J Med"},{"key":"29_CR41","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/archinte.165.8.936","volume":"165","author":"M Rahman","year":"2005","unstructured":"Rahman M, Pressel S, Davis BR, et al.: Renal outcomes in high-risk hypertensive patients treated with an angiotensinconverting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Int Med 2005, 165:936\u2013946.","journal-title":"Arch Int Med"},{"key":"29_CR42","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/archinte.162.14.1636","volume":"162","author":"JT Wright","year":"2002","unstructured":"Wright JT, Agodoa L, Contreras G, et al.: Successful blood pressure control in the African American study of Kidney Disease and Hypertension. Arch Int Med 2002, 162:1636\u20131643.","journal-title":"Arch Int Med"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-006-0029-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-006-0029-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-006-0029-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T23:50:58Z","timestamp":1683849058000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-006-0029-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["29"],"URL":"https:\/\/doi.org\/10.1007\/s11906-006-0029-4","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}